{"organizations": [], "uuid": "09e59f5fddd98433afa81e64f9fb0c5ade9d7a04", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.pharmamedtechbi.com", "main_image": "", "site_section": "http://feeds.feedburner.com/PharmaBiotechFinancing", "section_title": "Pharma/Biotech Financing From Elsevier Business Intelligence", "url": "https://www.pharmamedtechbi.com/deals/201530751?elsca1=custom&elsca2=rss&elsca3=%3ftype%3dDeals%26advanced%3d(%2540industries%253d%2522Pharmaceuticals%2522)%2520and%2520(%2540industries%253d%2522Biotechnology%2522)%2520and%2520(%2540dealtype%253d%2522Financing%2522)", "country": "IL", "title": "Can-Fite BioPharma nets $4.5mm in registered direct offering", "performance_score": 0, "site": "pharmamedtechbi.com", "participants_count": 0, "title_full": "Can-Fite BioPharma nets $4.5mm in registered direct offering", "spam_score": 0.0, "site_type": "news", "published": "2015-10-16T02:40:00.000+03:00", "replies_count": 0, "uuid": "09e59f5fddd98433afa81e64f9fb0c5ade9d7a04"}, "author": "", "url": "https://www.pharmamedtechbi.com/deals/201530751?elsca1=custom&elsca2=rss&elsca3=%3ftype%3dDeals%26advanced%3d(%2540industries%253d%2522Pharmaceuticals%2522)%2520and%2520(%2540industries%253d%2522Biotechnology%2522)%2520and%2520(%2540dealtype%253d%2522Financing%2522)", "ord_in_thread": 0, "title": "Can-Fite BioPharma nets $4.5mm in registered direct offering", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Can-Fite BioPharma nets $4.5mm in registered direct offering Deal Date: Oct-01-2015 / Deal # 201530751 Executive Summary \nIsraeli biotech Can-Fite BioPharma Ltd. netted $4.5mm in a registered direct offering with existing institutional investors. The company issued 1.1mm American Depository Shares (ADSs) at $4.35 (equal to 2.2mm ordinary shares). The investors will also receive warrants to purchase 40% of an ADS at $5.25, exercisable between six months after issuance until five and a half years after issuance. Can-Fite recently raised $9mm in September with the same investors.", "external_links": [], "published": "2015-10-16T02:40:00.000+03:00", "crawled": "2015-10-16T19:14:50.229+03:00", "highlightTitle": ""}